Benzgalantamine gluconate

葡萄糖酸苯加兰他敏

Report date: 2025/07/29 09:50:28
NME

Base Information

Drug NameBenzgalantamine gluconate
Drug Alias NamePro-galantamine-Galantos Pharma葡萄糖酸苄加兰他敏Galantamine pro-drugGalantamine benzoatePro-galantamine +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsCognitive DysfunctionAlzheimer DiseaseBrain Injuries, Traumatic
Global Approved IndicationsAlzheimer Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/07/26
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesGalantos Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesNeurodyn IncChina Medical System Holdings LtdAlpha Cognition Inc
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionAlzheimer DiseaseBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A